	US 11,872,203 B1
	Methods of administering solriamfetol to lactating women
Herriot Tabuteau, New York, NY (US)
Assigned to Axsome Malta Ltd., Qormi (MT)
Filed by Axsome Malta Ltd., Qormi (MT)
Filed on May 24, 2023, as Appl. No. 18/323,232.
Application 18/323,232 is a continuation of application No. 18/148,682, filed on Dec. 30, 2022, granted, now 11,771,666.
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/27 (2006.01); A61K 9/00 (2006.01); A61K 31/165 (2006.01)

CPC A61K 31/27 (2013.01) [A61K 9/0053 (2013.01)]

18 Claims

1. A method of reducing the risk of anorexia and/or reduced weight gain in an infant fed breast milk obtained from a subject treated with solriamfetol, comprising:

orally administering the solriamfetol to the subject at a daily dose of about 150 mg; and

feeding the infant breast milk obtained from the subject at least about 5 hours after administering the solriamfetol to the subject,

wherein the daily infant dose of solriamfetol is about 0.3 mg or lower.